InsiderTrades

Form 4 for BIO BIO-RAD LABORATORIES, INC.

Accepted 2025-04-25 00:00:00 ET · period of report 2025-04-24 · accession 0001062993-25-008078 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-04-25 2025-04-24 BIO Lakkaraju Roop Kalyan EVP, CFO M - OptEx $0.00 +1,077 1,231 +698% $0
D 2025-04-25 2025-04-24 BIO Lakkaraju Roop Kalyan EVP, CFO F - Tax $249.74 -386 845.38 -31% -$96.4K
D 2025-04-25 2025-04-24 BIO Lakkaraju Roop Kalyan EVP, CFO M - OptEx $0.00 -1,077 3,234 -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Bio-Rad A Common Stock 2025-04-24 M A 1,077 $0.00 1,231.38 D — — (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. (F2) Includes 66.8810 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2025.
2 Common Bio-Rad A Common Stock 2025-04-24 F D 386 $249.74 845.38 D — —
3 Derivative Restricted Stock Units 2025-04-24 M D 1,077 $0.00 3,234 D $0.00 · — to — 1,077 Bio-Rad A Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) On April 24, 2024, the reporting person was granted 4,311 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.